Shake Shack (NYSE:SHAK) Full Year 2024 Results
Key Financial Results
- Revenue: US$1.25b (up 15% from FY 2023).
- Net income: US$10.2m (down 50% from FY 2023).
- Profit margin: 0.8% (down from 1.9% in FY 2023).
- EPS: US$0.26 (down from US$0.51 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Shake Shack Meets Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.
Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 9.8% growth forecast for the Hospitality industry in the US.
Performance of the American Hospitality industry.
The company's shares are up 13% from a week ago.
Risk Analysis
We should say that we've discovered 2 warning signs for Shake Shack that you should be aware of before investing here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:SHAK
Shake Shack
Owns, operates, and licenses Shake Shack restaurants (Shacks) in the United States and internationally.
Solid track record with reasonable growth potential.
Market Insights
Weekly Picks

The "Sleeping Giant" Stumbles, Then Wakes Up
Swiped Left by Wall Street: The BMBL Rebound Trade

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For
Recently Updated Narratives
Hims & Hers Health aims for three dimensional revenue expansion
Endeavour Group's Future PE Expected to Climb to 15.51%
A Quality Compounder Marked Down on Overblown Fears
Popular Narratives

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
